Earlier this year, Ampersand Health and Calpro AS, a Svar Life Science firm, announced a partnership that will see the CalproSmart Self-Test integrated into Ampersand’s My IBD Care, a behavioural science-based digital treatment software for persons suffering from inflammatory bowel disease (IBD).
Incorporating the CalproSmart Self-Test into the app will allow patients to conduct the test from the comfort of their own homes and share the results with clinicians, who will review the results alongside lifestyle, symptom, and wearable data on a single dashboard portal that provides a comprehensive picture of a person’s health. Patient autonomy and self-management are enhanced as a result, and clinicians get a more accurate picture of illness development as a result of the increased accuracy.
Ampersand Health, which specializes in immune-mediated inflammatory disorders (IMIDs), has experienced tremendous success with their My IBD Care platform, which has been utilized by over 50,000 people in the UK, as well as by NHS Trusts across the country, to transform the long-term care of IBD.
As a result, care does not always coincide with a flare-up or a specific clinical need when it is most helpful and effective for patients with chronic conditions to visit the hospital on a regular basis for periodic reviews. With self-management help and remote monitoring capabilities, Ampersand Health’s digital therapy also serves as a bridge between clinicians and patients with these disorders. Rather than waiting until their next scheduled checkup, patients can obtain help when they need it most, tackling problems as they develop.
According to patient reports, practitioners are notified immediately when a patient may require special treatment or attention. This allows flares to be handled more promptly and effectively, typically addressing symptoms before they become more severe. Because of this, A&E admissions are down by 89%, healthcare service efficiency is up by 33% to 47%, and patients prefer this model over the old one by a wide margin.
When used in combination with a clinical team at a hospital that uses the platform, the app can help patients self-manage by providing educational resources and courses. Through two-way, asynchronous communication outside of regular outpatient appointments, My Arthritis works in partnership with a patient and their clinical team to facilitate patient-initiated follow-up and improve clinical safety for patients in virtual care, revolutionizing the way we provide care for people living with arthritis.
Patients with inflammatory bowel disease (IBD) can utilize the CalproSmart Self-Test at home to keep tabs on inflammation in the colon.
An e-health application reads the results and displays them, showing the patient’s inflammation level (mg/kg) with a traffic light indicator when they follow the simple step-by-step instructions and take a picture of the test cassette. This implies that flares may be handled swiftly and effectively, often treating symptoms before they become severe enough to warrant a full flare-up.
According to Calpro AS CEO, Anne Thjømøe, health care is becoming a part of our everyday lives – whether we are healthy or ill, young or elderly. Recently, E-Health has emerged as a valuable resource to help cancer patients achieve and maintain long-term remission. Because of this partnership, we will be able to provide patients and healthcare providers with cutting-edge treatments for individuals with inflammatory bowel disease in the future. We firmly believe that by working together, we can provide patients with better, safer, and more individualized treatment. The CalproSmart Self-Test, which is part of My IBD Care, frees up resources and time in hospitals for physicians, allowing them to focus on providing care while also empowering, involving, and informing patients living with long-term inflammatory
